The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N05 | Psycholeptics | |
| 3 | N05A | Antipsychotics | |
| 4 | N05AN | Lithium |
| Code | Title | |
|---|---|---|
| N05AN01 | Lithium |
| Active Ingredient | Description | |
|---|---|---|
| Lithium |
Little is known about the way the lithium ion can modify neurotransmission within the CNS. Many of the proposed mechanisms have suggested an inhibitory effect on components of various neurotransmitter signalling pathways, such as cyclic AMP formation, cyclic GMP formation, G-proteins or inositol phosphate metabolism. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CAMCOLIT Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| PRIADEL Prolonged-release tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
